These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10928804)

  • 1. A study of the frequency of contamination of products applied to the skin.
    Hamilton D; Hamilton B
    Dermatol Surg; 2000 Jul; 26(7):713-4. PubMed ID: 10928804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter: Microbiological degree of purity in dermatologic external agents].
    Eyer H; Führer C; Paetzold OH
    Hautarzt; 1975 Mar; 26(3):167-8. PubMed ID: 1126850
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbial contamination of topical medicaments used in the treatment and prevention of pressure sores.
    Baird RM; Farwell JA; Sturgiss M; Awad ZA; Shooter RA
    J Hyg (Lond); 1979 Dec; 83(3):445-50. PubMed ID: 117050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic development of topical dermatologic products, Part II: quality by design for topical semisolid products.
    Chang RK; Raw A; Lionberger R; Yu L
    AAPS J; 2013 Jul; 15(3):674-83. PubMed ID: 23572241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of skin disinfection materials on reducing blood culture contamination.
    Schifman RB; Pindur A
    Am J Clin Pathol; 1993 May; 99(5):536-8. PubMed ID: 8493946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yes to Appropriate Compounding, No to Illegal Compounding.
    Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s15-s16. PubMed ID: 30005108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update of the Brazilian Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products.
    Soares KC; Santos GM; Gelfuso GM; Gratieri T
    AAPS J; 2015 Nov; 17(6):1517-8. PubMed ID: 26122498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial contamination of pharmaceutical products in the home.
    Baird RM; Crowden CA; O'Farrell SM; Shooter RA
    J Hyg (Lond); 1979 Oct; 83(2):277-83. PubMed ID: 385768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiseptics: sometimes the cause of infection.
    Prescrire Int; 2014 May; 23(149):129. PubMed ID: 24926517
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical steroids and bacterial infection.
    Savin JA
    Br J Dermatol; 1976 Mar; 94 suppl 12():125-8. PubMed ID: 1268073
    [No Abstract]   [Full Text] [Related]  

  • 11. Do topical products reduce postincision scars?
    Hom DB; Hom KA
    Laryngoscope; 2015 Feb; 125(2):282-3. PubMed ID: 24945617
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
    Katare OP; Raza K; Singh B; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Localized bacterial skin infections and dermatologic manifestations of systemic infections].
    Zimmerli W; Itin P
    Ther Umsch; 1992 Apr; 49(4):250-6. PubMed ID: 1615460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contaminated medicaments in use in a hospital for diseases of the skin.
    Baird RM; Awad ZA; Shooter RA; Noble WC
    J Hyg (Lond); 1980 Feb; 84(1):103-8. PubMed ID: 6766154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial contamination of drugs (author's transl)].
    Hurtado R; Mimica I; Lynch B; Valenzuela MC; Cabezas P; Kojchen L; Meneses J; Meneses P; Merello G; Molina MT; Montenegro A
    Rev Med Chil; 1974 Jul; 102(7):507-10. PubMed ID: 4471389
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and structural elucidation of abietic acid as the main adulterant in an herbal drug for the treatment of psoriasis.
    He Y; Zhang Y; Lu J; Lin R
    J Pharm Biomed Anal; 2012 Jul; 66():345-8. PubMed ID: 22482903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active ingredients, pharmaceutic aids and efficacy of topical drugs].
    Zesch A
    Hautarzt; 1988 May; 39(5):267-9. PubMed ID: 3403261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical preparations and their use in dermatology.
    Wohlrab J
    J Dtsch Dermatol Ges; 2016 Nov; 14(11):1061-1070. PubMed ID: 27879084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of pregnancy warnings on over-the-counter dermatologic products containing potentially harmful hydroquinone.
    Bio LL; Cies JJ
    J Perinatol; 2017 Jul; 37(7):778-781. PubMed ID: 28358386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of bacterial contamination in blood and blood products at the National Blood Service Zimbabwe.
    Makuni N; Simango C; Mavenyengwa RT
    J Infect Dev Ctries; 2015 Apr; 9(4):421-4. PubMed ID: 25881533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.